Haseeb Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.42 Cr
as on 16-11-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.11 Cr
as on 16-11-2024
- Satisfied Charges ₹ 22.56 Cr
as on 16-11-2024
- Revenue -0.88%
(FY 2023)
- Profit -28.48%
(FY 2023)
- Ebitda -0.76%
(FY 2023)
- Net Worth 7.89%
(FY 2023)
- Total Assets 11.44%
(FY 2023)
About Haseeb Pharmaceuticals
The Corporate was formerly known as Haseeb Pharamaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 1.42 Cr.
The company currently has active open charges totaling ₹26.11 Cr. The company has closed loans amounting to ₹22.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Kukreja and Sanjay Cheturam serve as directors at the Company.
- CIN/LLPIN
U24230MH1999PTC119395
- Company No.
119395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Haseeb Pharmaceuticals Private Limited offer?
Haseeb Pharmaceuticals Private Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant.
Who are the key members and board of directors at Haseeb Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Kukreja  | Director | 14-Mar-2022 | Current |
| Sanjay Cheturam | Director | 14-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Haseeb Pharmaceuticals.
Haseeb Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.88% decrease. The company also saw a substantial fall in profitability, with a 28.48% decrease in profit. The company's net worth moved up by a moderate rise of 7.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Haseeb Pharmaceuticals?
In 2023, Haseeb Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adroit Pharmaceuticals Private LimitedActive 47 years 7 monthsBhupendra Kukreja and Sanjay Cheturam are mutual person
- Household Pharmaceuticals LimitedActive 30 years 9 months
Bhupendra Kukreja and Sanjay Cheturam are mutual person
- Heil German Pharmaceuticals Private LimitedActive 14 years 1 month
Bhupendra Kukreja and Sanjay Cheturam are mutual person
- Leela Organics Private LimitedActive 4 years 2 months
Bhupendra Kukreja and Sanjay Cheturam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 15 May 2023 | ₹6.18 Cr | Open |
Axis Bank Limited Creation Date: 28 Sep 2022 | ₹19.93 Cr | Open |
Others Creation Date: 16 Jun 2017 | ₹8.00 M | Satisfied |
How Many Employees Work at Haseeb Pharmaceuticals?
Haseeb Pharmaceuticals has a workforce of 92 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Haseeb Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haseeb Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
